Department of Defense Grant for Collaborative Translational Research in Toxic Exposures

Summary: The intent of the FY25 Toxic Exposures Research Program (TERP) Translational Research Partnership Award (TRPA) is to support new or existing collaborative partnerships to pursue translational research that will accelerate the movement of promising ideas in military-related toxic exposure research into clinical applications, including health care products, interventions, technologies, and/or clinical practice guidelines. Translational research may be defined as an integration of basic science and clinical observations. New Approach Methodologies may also be used. Applications should provide evidence for the reciprocal transfer of information between basic and clinical science or vice versa in developing and implementing the research plan.

Distinctive Features: To encourage applications that include meaningful and productive collaborations between investigators, the FY25 TERP TRPA requires partnership of the Initiating Principal Investigator (PI) with at least one, and up to two, other collaborating PIs for the completion of one overarching study. The intent is to support interdisciplinary partnerships, such as those between clinicians and research scientists that will accelerate the movement of promising ideas into clinical applications.

Summary: The intent of the FY25 Toxic Exposures Research Program (TERP) Translational Research Partnership Award (TRPA) is to support new or existing collaborative partnerships to pursue translational research that will accelerate the movement of promising ideas in military-related toxic exposure research into clinical applications, including health care products, interventions, technologies, and/or clinical practice guidelines. Translational research may be defined as an integration of basic science and clinical observations. New Approach Methodologies may also be used. Applications should provide evidence for the reciprocal transfer of information between basic and clinical science or vice versa in developing and implementing the research plan.

Distinctive Features: To encourage applications that include meaningful and productive collaborations between investigators, the FY25 TERP TRPA requires partnership of the Initiating Principal Investigator (PI) with at least one, and up to two, other collaborating PIs for the completion of one overarching study. The intent is to support interdisciplinary partnerships, such as those between clinicians and research scientists that will accelerate the movement of promising ideas into clinical applications.

Summary: The intent of the FY25 Toxic Exposures Research Program (TERP) Translational Research Partnership Award (TRPA) is to support new or existing collaborative partnerships to pursue translational research that will accelerate the movement of promising ideas in military-related toxic exposure research into clinical applications, including health care products, interventions, technologies, and/or clinical practice guidelines. Translational research may be defined as an integration of basic science and clinical observations. New Approach Methodologies may also be used. Applications should provide evidence for the reciprocal transfer of information between basic and clinical science or vice versa in developing and implementing the research plan.

Distinctive Features: To encourage applications that include meaningful and productive collaborations between investigators, the FY25 TERP TRPA requires partnership of the Initiating Principal Investigator (PI) with at least one, and up to two, other collaborating PIs for the completion of one overarching study. The intent is to support interdisciplinary partnerships, such as those between clinicians and research scientists that will accelerate the movement of promising ideas into clinical applications.